bleomycetin has been researched along with Lymph Node Metastasis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CHEN, XD; LÜ, WG; QIN, JL; SHI, HY | 1 |
Sun, ML; Wang, CM; Wen, YM; Xie, WH | 1 |
Gong, L; Liu, H; Lou, JY; Peng, ZL; Wang, P; Zhang, JW | 1 |
Li, LJ; Sun, ML; Wang, CM; Wang, XY; Wen, YM | 1 |
Chen, ZM; Jiang, Y; Qiu, XH; Yang, YX; Zhang, SQ | 1 |
Chernos, ZV; Gorbunova, VA; Manziuk, LV; Tikhonina, AM | 1 |
Lichinitser, MR; Tiuliandin, SA | 1 |
1 trial(s) available for bleomycetin and Lymph Node Metastasis
Article | Year |
---|---|
[Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Proportional Hazards Models; Remission Induction; Survival Rate | 2006 |
6 other study(ies) available for bleomycetin and Lymph Node Metastasis
Article | Year |
---|---|
[Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Period; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Vincristine; Young Adult | 2011 |
[Lymphatic targeting study of pingyangmycin-activated carbon nanoparticles treating oral cancer lymph node metastasis].
Topics: Animals; Bleomycin; Carbon; Lymph Nodes; Lymphatic Metastasis; Mice; Mouth Neoplasms; Nanoparticles; Neck | 2011 |
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Hysterectomy; Ifosfamide; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |
[Preparation of lymphatic targeting dosage form: pingyangmycin absorbed on activated carbon nanoparticles].
Topics: Antibiotics, Antineoplastic; Bleomycin; Carbon; Carcinoma, Squamous Cell; Humans; Injections, Intralymphatic; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Nanoparticles; Neck | 2004 |
[Belomycetin in the combined chemotherapy of testicular tumors].
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Bleomycin; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Humans; Lymphatic Metastasis; Male; Testicular Neoplasms; Time Factors; Vinblastine | 1983 |
[Use of bleomycetin in malignant testicular tumors and the problem of studying bleomycin analogs].
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Drug Evaluation; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Testicular Neoplasms; Time Factors; Vinblastine | 1984 |